5.3 Phonophoresis Protocols & Ultrasound-Electrotherapy Combination

Phonophoresis Protocols & Ultrasound-Electrotherapy Combination

Therapeutic ultrasound can be paired with topically applied pharmaceuticals (Phonophoresis) or delivered simultaneously with electrical stimulation (Ultrasound-Electrotherapy Combination Therapy). These advanced modalities represent vital therapeutic strategies in chiropractic rehabilitation for managing focal inflammatory tendinopathies, deep myofascial trigger points, and hypertonic muscle guarding.

Understanding the biophysical mechanisms of transdermal acoustic transport, pharmacological properties and vehicle transmissivity, delivery parameters, and the electrical configuration of combination therapy is critical for safe practice and represents high-yield content on the NBCE Physiotherapy Examination.

---

Biophysics of Phonophoresis & Transdermal Drug Transport

Phonophoresis (also termed sonophoresis) is defined as the transdermal delivery of topically applied pharmacological agents into underlying subcutaneous tissues using acoustic ultrasound waves.

Overcoming the Stratum Corneum Barrier

The outermost layer of human epidermis, the stratum corneum, serves as the primary physiological barrier protecting the body against chemical absorption and environmental pathogens.

• The "Bricks and Mortar" Architecture: The stratum corneum consists of flattened, keratin-packed dead corneocytes ("bricks") surrounded by an extracellular continuous matrix of ordered, hydrophobic lipid bilayers containing ceramides, cholesterol, and free fatty acids ("mortar").
• Under normal passive conditions, the stratum corneum is virtually impermeable to hydrophilic compounds and restricts the passive diffusion of lipophilic drugs to small molecules possessing a molecular weight below 500 Daltons. Most therapeutic corticosteroids and analgesics cannot penetrate this barrier in therapeutic quantities through simple topical rubbing.

Acoustic Mechanisms of Transdermal Permeabilization

Ultrasound overcomes the stratum corneum barrier not by heating, but through mechanical disruption induced by acoustic cavitation and microstreaming:

1. Cavitation-Induced Lipid Disorganization: High-frequency acoustic pressure waves induce stable cavitation within the aqueous compartments between intercellular lipid bilayers. The cyclic oscillation and collapse of microscopic gas bubbles generate micro-shock waves that violently disorder the highly packed, crystalline lamellar lipid bilayers. This creates transient aqueous micro-conduits (micropores) through which large drug molecules can diffuse.
2. Microstreaming & Shear Stress: Acoustic eddy currents exert localized shear stresses against keratinized corneocytes, increasing cellular membrane permeability.
3. Acoustic Radiation Force: The forward acoustic pressure waves exert a direct physical momentum (radiation force), driving whole drug molecules through the temporary micropores into the vascularized epidermis and dermis.
4. Tissue Penetration Depth: Phonophoresis drives medications directly across the epidermal barrier to depths of 1 to 5 millimeters, from which point local microcirculation and tissue diffusion distribute the drug into underlying targeted tendons, bursae, ligaments, and muscle bellies at depths of 2 to 6 centimeters.

---

Pharmacological Agents, Compounding & Vehicle Transmissivity

Phonophoresis utilizes anti-inflammatory corticosteroids, local anesthetics, or non-steroidal anti-inflammatory drugs (NSAIDs) to treat localized musculoskeletal pathology.

Primary Pharmacological Agents

• 10% Hydrocortisone (Cream or Ointment): The most frequently prescribed and tested phonophoresis agent. A natural glucocorticoid that blocks phospholipase A2, inhibiting the arachidonic acid cascade and suppressing prostaglandin and leukotriene synthesis. Highly indicated for acute and subacute tendinitis, tenosynovitis, bursitis, and epicondylalgia.
• 0.4% Dexamethasone Sodium Phosphate: A synthetic, highly potent, water-soluble fluorinated corticosteroid. It possesses approximately 25 to 30 times the anti-inflammatory potency of hydrocortisone with zero mineralocorticoid (sodium-retaining) activity.
• 1% to 2% Lidocaine Hydrochloride: An amino-amide local anesthetic that reversibly blocks voltage-gated sodium channels along peripheral nerve axons, inhibiting action potential conduction. Indicated for immediate, short-term relief of acute bursitis, superficial neuralgias, and hyper-irritable myofascial trigger points.
• Topical NSAIDs (Ketoprofen, Diclofenac / Voltaren Gel): Directly inhibit cyclooxygenase (COX-1 and COX-2) enzymes to halt prostaglandin synthesis. Provide powerful localized anti-inflammatory and analgesic effects without the risks of corticosteroid-induced collagen tendon degradation or subcutaneous fat atrophy.

The Problem of Vehicle Acoustic Transmissivity

A frequent and critical error in clinical practice is assuming that any commercial pharmaceutical cream can transmit ultrasound waves:

• Acoustic Opacity of Standard Creams: Many commercially prepared topical creams, heavy white ointments, and balms contain mineral oil, white petrolatum, or suspended particulates. These oily emollients contain microscopic trapped air bubbles and exhibit high acoustic impedance mismatches, reflecting or absorbing 70% to 90% of incident acoustic energy. Applying an ultrasound soundhead over a standard thick white cream results in virtually zero sound transmission into tissue and risks overheating the transducer crystal.
• Acoustically Transparent Vehicles: To conduct ultrasound waves effectively, the drug must be compounded within an aqueous, bubble-free gel base (such as pure carboxymethylcellulose or ultrasound gel).

Approved Clinical Application Techniques

To ensure both acoustic transmission and drug penetration, clinicians utilize three standard delivery methods:

1. The Inunction Technique (Most Popular & Practical): The clinician rubs a thin, uniform film of the pharmacological cream directly into the target skin area for 1 to 2 minutes. A generous layer of standard, bubble-free acoustic ultrasound transmission gel is then applied directly over the medication. The ultrasound transducer is placed on the gel, transmitting acoustic waves through the gel to drive the underlying drug transdermally.
2. The 50/50 Direct Mixture Technique: The pharmacological cream or ointment is mixed directly with standard ultrasound transmission gel in a 1:1 ratio and applied to the target site. Note: While widely used, this dilutes drug concentration by 50%.
3. Pre-Compounded Phonophoresis Gels: Specially formulated, acoustically transparent aqueous gels that contain pre-dissolved active pharmaceuticals (such as dexamethasone or ketoprofen) manufactured specifically for ultrasound delivery.

---

Phonophoresis Delivery Parameters & Clinical Protocol

To deliver medications safely and effectively, the clinician must configure parameters based on pathology and physiological targets:

1. Duty Cycle Selection: Pulsed vs. Continuous

• Pulsed Mode (20% Duty Cycle) — Standard Recommendation: For acute and subacute inflammatory conditions (such as acute tendinitis or bursitis), pulsed ultrasound (20% duty cycle) is the primary mode of choice.
  • Biophysical Rationale: Continuous ultrasound generates vigorous tissue heating and arteriolar vasodilation. Accelerated regional capillary blood flow rapidly washes topically absorbed drug molecules away into the general systemic circulation before they can accumulate at therapeutic concentrations within the local target tissue. Pulsed ultrasound provides non-thermal cavitation and microstreaming to permeabilize the stratum corneum without increasing local blood flow, ensuring high local drug retention.
• Continuous Mode (100% Duty Cycle): Reserved exclusively for chronic, non-acute conditions (such as chronic fibrotic tendon thickening or calcific tendinopathy) where simultaneous deep heating and collagen extensibility are desired.

2. Frequency Selection

• 3 MHz: Indicated for superficial inflammatory targets located within 1 to 2 cm of the skin surface (lateral/medial epicondylitis, patellar tendinitis, carpal tunnel, Achilles tendinitis, bicipital tendinitis).
• 1 MHz: Indicated for deep targets located 3 to 5 cm beneath the skin (deep trochanteric bursitis, piriformis syndrome, deep gluteal tendinopathies).

3. Intensity and Duration

• Intensity: Typically dialed to $1.0\text{ to }1.5\text{ W/cm}^2$ for pulsed mode ($0.5\text{ to }1.0\text{ W/cm}^2$ if continuous mode is selected).
• Treatment Duration: 5 to 10 minutes per treatment zone (approximately 5 minutes per area measuring 2 times the ERA).
• Treatment Frequency & Corticosteroid Limits: Corticosteroid phonophoresis treatments should be spaced at least 48 hours apart (2 to 3 times per week). Total treatments must be limited to a maximum of 6 to 8 sessions. Excessive local corticosteroid exposure inhibits fibroblast protein synthesis, leading to collagen fiber degradation, subcutaneous adipose atrophy, and risk of spontaneous tendon rupture (especially of the Achilles or patellar tendon).

---

Ultrasound-Electrotherapy Combination Therapy

Ultrasound-Electrotherapy Combination Therapy involves the simultaneous delivery of acoustic ultrasound energy and electrical stimulation through a single integrated modality setup.

Biophysical Configuration & Circuitry

The unique engineering feature of combination therapy is that the metal faceplate of the ultrasound transducer serves a dual role: it functions as the acoustic soundhead and simultaneously acts as the active electrical electrode:

• Electrical Circuitry: An electrical lead from an external electrotherapy generator is routed internally to the metal faceplate of the transducer. A separate, large dispersive electrode is connected to the generator to complete the electrical circuit.
• Active Electrode Polarity (Cathode): The soundhead is configured as the active cathode (negative pole). According to neurophysiological principles of electrotherapy, the cathode produces a localized accumulation of negative charges that hypopolarizes adjacent nerve membranes, lowering their excitation threshold. This enables motor and sensory axons to depolarize at lower electrical amplitudes.
• Dispersive Electrode (Anode): A large, rectangular conductive pad (at least 2 to 4 times the area of the soundhead) is placed on a distant, indifferent muscular site (e.g., contralateral lumbar area or upper back) to disperse electrical current safely without eliciting sensory or motor stimulation.

Synergistic Physiological Benefits

Simultaneous application produces profound clinical synergy:

1. Acoustic Effects: High-frequency sound waves deliver micromassage, stable cavitation, and thermal relaxation deep into muscle bellies, decreasing tissue impedance and increasing cell membrane permeability.
2. Electrical Stimulation Effects: Modalities such as High-Voltage Pulsed Current (HVPC), Premodulated Current, or Interferential Current (IFC) depolarize motor axons to elicit rhythmic muscle contractions that pump out metabolic waste, induce muscle fatigue to break hypertonic splinting, and stimulate A-beta sensory fibers for immediate Gate Control pain relief.

Diagnostic & Therapeutic Targeting of Myofascial Trigger Points

Combination therapy is widely recognized as the premier physical modality for identifying and resolving deep myofascial trigger points:

• Diagnostic Localization: Myofascial trigger points and motor points exhibit significantly lower electrical impedance than surrounding normal muscle tissue. As the clinician slowly glides the energized soundhead across a taut muscle band, the electrical current selectively funnels into the low-impedance trigger point. The patient experiences a sudden, distinct sensory "bite" or visible local muscle twitch directly over the trigger point, pinpointing its exact anatomical location.
• Therapeutic Deactivation: Once localized, the clinician focuses soundhead movement over the trigger point zone. The combined mechanical acoustic vibration and electrical motor stimulation exhaust motor endplate acetylcholine stores, breaking the sustained actin-myosin contraction knot and restoring regional microvascular blood flow.

Step-by-Step Clinical Procedure for Combination Therapy

1. Informed Consent & Skin Inspection: Explain the sensations (gentle warmth and electrical tingling/muscle twitches); inspect skin for lesions, contraindications, or sensory deficits.
2. Dispersive Electrode Placement: Moisten and secure a large dispersive electrode pad to a distant, comfortable site on the patient's body to complete the electrical circuit.
3. Gel Application: Apply a generous layer of aqueous ultrasound transmission gel to the target muscle group and transducer faceplate.
4. Skin Contact Before Power: Place the soundhead firmly against the patient's skin. Never activate ultrasound or electrical stimulation while the soundhead is held in the air!
5. Set Electrical Parameters: Select the desired electrical waveform (HVPC at 100–120 pps for sensory gating or 35–50 pps for motor contraction; or Premodulated / IFC). Slowly increase electrical intensity while moving the soundhead until the patient reports a definite, comfortable tingling or until a mild motor contraction is observed.
6. Set Ultrasound Parameters: Select frequency (1 MHz for deep muscle bellies, 3 MHz for superficial structures) and duty cycle (continuous for chronic trigger points; pulsed 20% for acute irritable points). Dial intensity to $1.0\text{ to }1.5\text{ W/cm}^2$.
7. Maintain Continuous Motion: Glide the soundhead continuously across the muscle belly in overlapping circular strokes at 3 to 4 cm/second. When a trigger point is identified (sudden jump or twitch), maintain localized small circular movements over the zone for 1 to 2 minutes.
8. Treatment Conclusion: Always turn down the ultrasound intensity first, then turn down the electrical stimulation amplitude to zero. Turn off the unit, remove the soundhead from the skin, wipe gel from the patient and transducer, and re-assess muscle tone and active range of motion.

---

Phonophoresis vs. Iontophoresis: Comparative Analysis

A hallmark area of testing on the NBCE Physiotherapy Examination is the direct clinical and biophysical comparison between Phonophoresis and Iontophoresis. While both modalities achieve transdermal drug delivery without hypodermic injection, their driving forces, pharmacological requirements, and clinical risk profiles diverge completely: